Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - ImmuLogic Pharm. Corp. (OTC BB:IMUL.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Financials
Location
610 Lincoln Street
Waltham, MA 02154
Phone: (781) 466-6000
Fax: (781) 466-6010
Employees (last reported count): 5
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Related Links
 ·Search Yahoo! for related links...
Ownership
·Insider and 5%+ Owners: 35%
·Institutional: 4% (7% of float)
(3 institutions)
·Net Inst. Buying: 321.0K shares (+26.73%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
ImmuLogic Pharmaceutical Corporation is a biopharmaceutical company. On March 23 1999, the Board of Directors approved a plan to liquidate and dissolve the Company. The plan was approved by a majority of the stockholders of the Company on August 25, 1999. ImmuLogic's material proprietary rights consisted of patents and licenses to patents in the following areas: general immunotherapy and autoimmune, allergy and drug abuse therapy. The Company's rights relating to general immunotherapy were licensed from Washington University and the Massachusetts Institute of Technology (MIT). The licenses from Washington University and MIT terminated in 1999. The Company's patents relating to allergy therapy were transferred to Heska Corporation in 1999. The Company's patents relating to drug abuse therapy were sold to Cantab Pharmaceuticals plc on February 2, 1999.
More from Market Guide: Expanded Business Description

Financial Summary
IMUL is a biopharmaceutical company that develops products to treat allergies and autoimmune diseases. In 1999, the Company approved a plan to liquidate and dissolve its assets. For the six months ended 6/30/99, revenues increased 13% to $1.1 million. Net loss increased 9% to $2.1 million. Revenues reflect research and development services performed for Cantab Pharmaceuticals. Higher loss reflects the inclusion of a $966 thousand loss on leasehold improvements.
More from Market Guide: Significant Developments

Officers
FY1999 Pay

J. Richard Crowley, 44
Pres, Sec. and Treasurer
$220K
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:IMUL.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 17-Jan-2001
$0.047
Recent Price$0.06 
52-Week High
on 1-Sep-2000
$0.672
Beta1.04 
Daily Volume (3-month avg)12.6K
Daily Volume (10-day avg)25.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-90.4%
52-Week Change
relative to S&P500
-87.1%
Share-Related Items
Market Capitalization$1.22M
Shares Outstanding20.4M
Float13.2M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$2.50 
Earnings (ttm)-$0.02 
Earnings (mrq)-$0.05 
Sales (ttm)$0.22 
Cash (mrq)$1.22 
Valuation Ratios
Price/Book (mrq)0.02 
Price/EarningsN/A 
Price/Sales (ttm)0.27 
Income Statements
Sales (ttm)$4.47M
EBITDA (ttm)-$3.16M
Income available to common (ttm)-$476.0K
Profitability
Profit Margin (ttm)-10.6%
Operating Margin (ttm)-65.6%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-1999
Management Effectiveness
Return on Assets (ttm)-0.87%
Return on Equity (ttm)-0.91%
Financial Strength
Current Ratio (mrq)18.18 
Debt/Equity (mrq)0 
Total Cash (mrq)$24.9M
Short Interest
As of 10-Jan-2000
Shares Short6,000 
Percent of Float0.0%
Shares Short
(Prior Month)
0 
Short Ratio0.00 
Daily Volume1.59M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-1999)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.